MBIO
Mustang Bio, Inc.NASDAQHealthcare$0.78-2.45%ClosedMarket Cap: $5.9M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.58
P/S
0.00
EV/EBITDA
5.40
DCF Value
$0.29
FCF Yield
-91.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-29.8%
ROA
-10.9%
ROIC
-25.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | NaN% | $-670.0K | $-538.0K | $-0.07 | — |
| FY 2025 | $0.00 | -Infinity% | $-2.4M | $-1.9M | $-0.39 | — |
| Q3 2025 | $0.00 | NaN% | $-624.0K | $-468.0K | $-0.08 | — |
| Q2 2025 | $0.00 | NaN% | $-885.0K | $-762.0K | $-0.13 | — |
| Q1 2025 | $0.00 | -Infinity% | $-253.0K | $-153.0K | $-0.05 | — |
| Q4 2024 | $0.00 | NaN% | $-1.0M | $-952.0K | $-0.95 | — |
| FY 2024 | $0.00 | NaN% | $-16.2M | $-15.8M | $-2.57 | — |
| Q3 2024 | $0.00 | NaN% | $-1.5M | $-1.4M | $-0.16 | — |
| Q2 2024 | $0.00 | NaN% | $-8.5M | $-8.2M | $-0.94 | — |
| Q1 2024 | $0.00 | -Infinity% | $-5.2M | $-5.2M | $-0.46 | — |
| Q4 2023 | $0.00 | NaN% | $-8.7M | $-8.6M | $-0.93 | — |
| FY 2023 | $0.00 | -Infinity% | $-50.7M | $-51.6M | $-6.00 | — |